This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ueland, T. Articles by Djøseland, O. Search for Related Content PubMed PubMed Citation Articles by Ueland, T. Articles by Djøseland, O.

Increased Cortical Bone Content of Insulin-Like Growth Factors in Acromegalic Patients¹

Department of Endocrinology, National University Hospital (T.U., J.B., O.D.), N-0027 Oslo, Norway; the Department of Endocrinology, Odense University Hospital (T.B.H., E.N.E.), DK-5000 Odense, Denmark; and the Department of Cell Biology, University of Aarhus (L.M.), and the Department of Endocrinology (K.B.) and the Medical Research Laboratory M (A.F.), Aarhus University Hospital, DK-8000 Aarhus, Denmark

Address all correspondence and requests for reprints to: Dr. Thor Ueland, Department of Endocrinology, National University Hospital, N-0027 Oslo, Norway.

To investigate cortical bone composition and the role of the insulin-like growth factor (IGF) system in active acromegaly, iliac crest bone biopsies were obtained from 15 patients (3 women and 12 men), aged 21–64 yr (mean, 45.6 yr), and 25 age- and sex-matched controls (8 women and 17 men), aged 22–66 yr (mean, 44.6 yr). Levels of IGF-I, IGF-II, IGF-binding protein-3 (IGFBP-3), IGFBP-5, and total protein were determined in extracts obtained after ethylenediamine tetraacetate and guanidine hydrochloride extraction. Osteocalcin and calcium were determined in extracts after HCl hydrolysis. Cortical bone contents of IGF-I, IGF-II, and IGFBP-5 were significantly elevated in the acromegalic patients compared with control values [91% (P < 0.001), 44% (P < 0.04), and 115% (P < 0.004), respectively]. There was no significant difference in IGFBP-3, osteocalcin, protein, and calcium between patients and controls. This study suggests that the increased levels of growth factors in cortical bone from acromegalics is a reflection of local production, secondary to a chronic systemic excess of GH and IGF-I.

This article has been cited by other articles:

				T Ueland, S L Fougner, K Godang, T Schreiner, and J Bollerslev Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients. Eur. J. Endocrinol., November 1, 2006; 155(5): 709 - 715. [Abstract] [Full Text] [PDF]

				T. Ueland, K. Brixen, L. Mosekilde, L. Mosekilde, A. Flyvbjerg, and J. Bollerslev Age-Related Changes in Cortical Bone Content of Insulin-Like Growth Factor Binding Protein (IGFBP)-3, IGFBP-5, Osteoprotegerin, and Calcium in Postmenopausal Osteoporosis: A Cross-Sectional Study J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1014 - 1018. [Abstract] [Full Text] [PDF]

				T. Ueland, J. Bollerslev, A. Flyvbjerg, T. B. Hansen, N. Vahl, and L. Mosekilde Effects of 12 Months of GH Treatment on Cortical and Trabecular Bone Content of IGFs and OPG in Adults with Acquired GH Deficiency: A Double-Blind, Randomized, Placebo-Controlled Study J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2760 - 2763. [Abstract] [Full Text] [PDF]

				J. D. Wallace, R. C. Cuneo, P. A. Lundberg, T. Rosén, J. O. L. Jørgensen, S. Longobardi, N. Keay, L. Sacca, J. S. Christiansen, B.-A. Bengtsson, et al. Responses of Markers of Bone and Collagen Turnover to Exercise, Growth Hormone (GH) Administration, and GH Withdrawal in Trained Adult Males J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 124 - 133. [Abstract] [Full Text]